View in EDS HTML Full Text PDF Full Text

Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease.

Saved in:
Bibliographic Details
Title: Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease.
Authors: Roblin X; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France., Nancey S; Department of Gastroenterology, Lyon-Sud Hospital, Hospices Civils de Lyon, University Claude Bernard Lyon 1 and CIRI (Centre International de Recherche en Infectiologie), INSERM U1111, Lyon, France., Papamichael K; Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Centre, Boston, Massachusetts, USA., Mechi F; Immunology Laboratory/iBioThera, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France.; CIRI, Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, Saint-Etienne, France., Ouvrier-Buffet J; Immunology Laboratory/iBioThera, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France.; CIRI, Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, Saint-Etienne, France., Charlois AL; Department of Gastroenterology, Lyon-Sud Hospital, Hospices Civils de Lyon, University Claude Bernard Lyon 1 and CIRI (Centre International de Recherche en Infectiologie), INSERM U1111, Lyon, France., Peaucelle AS; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France., Bastide L; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France., Berger AA; Immunology Laboratory/iBioThera, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France.; CIRI, Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, Saint-Etienne, France., Barrau M; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France., Cheifetz AS; Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Centre, Boston, Massachusetts, USA., Duru G; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France., Paul S; Immunology Laboratory/iBioThera, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France.; CIRI, Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, Saint-Etienne, France.
Source: United European gastroenterology journal [United European Gastroenterol J] 2026 Apr; Vol. 14 (3), pp. e70207.
Publication Type: Journal Article; Observational Study; Comparative Study
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 101606807 Publication Model: Print Cited Medium: Internet ISSN: 2050-6414 (Electronic) Linking ISSN: 20506406 NLM ISO Abbreviation: United European Gastroenterol J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41880240
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Roblin+X%22">Roblin X</searchLink>; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Nancey+S%22">Nancey S</searchLink>; Department of Gastroenterology, Lyon-Sud Hospital, Hospices Civils de Lyon, University Claude Bernard Lyon 1 and CIRI (Centre International de Recherche en Infectiologie), INSERM U1111, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Papamichael+K%22">Papamichael K</searchLink>; Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Centre, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Mechi+F%22">Mechi F</searchLink>; Immunology Laboratory/iBioThera, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France.; CIRI, Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Ouvrier-Buffet+J%22">Ouvrier-Buffet J</searchLink>; Immunology Laboratory/iBioThera, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France.; CIRI, Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Charlois+AL%22">Charlois AL</searchLink>; Department of Gastroenterology, Lyon-Sud Hospital, Hospices Civils de Lyon, University Claude Bernard Lyon 1 and CIRI (Centre International de Recherche en Infectiologie), INSERM U1111, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Peaucelle+AS%22">Peaucelle AS</searchLink>; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Bastide+L%22">Bastide L</searchLink>; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Berger+AA%22">Berger AA</searchLink>; Immunology Laboratory/iBioThera, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France.; CIRI, Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Barrau+M%22">Barrau M</searchLink>; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Cheifetz+AS%22">Cheifetz AS</searchLink>; Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Centre, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Duru+G%22">Duru G</searchLink>; Department of Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Paul+S%22">Paul S</searchLink>; Immunology Laboratory/iBioThera, CIC1408, University Hospital of Saint-Etienne, Saint-Etienne, France.; CIRI, Université Claude Bernard Lyon 1, INSERM U1111, CNRS, UMR5308, ENS Lyon, Université Jean Monnet de Saint-Etienne, Saint-Etienne, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101606807%22">United European gastroenterology journal</searchLink> [United European Gastroenterol J] 2026 Apr; Vol. 14 (3), pp. e70207.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101606807 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2050-6414 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220506406%22">20506406 </searchLink><i>NLM ISO Abbreviation: </i>United European Gastroenterol J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41880240
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ueg2.70207
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70207
    Titles:
      – TitleFull: Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roblin X
      – PersonEntity:
          Name:
            NameFull: Nancey S
      – PersonEntity:
          Name:
            NameFull: Papamichael K
      – PersonEntity:
          Name:
            NameFull: Mechi F
      – PersonEntity:
          Name:
            NameFull: Ouvrier-Buffet J
      – PersonEntity:
          Name:
            NameFull: Charlois AL
      – PersonEntity:
          Name:
            NameFull: Peaucelle AS
      – PersonEntity:
          Name:
            NameFull: Bastide L
      – PersonEntity:
          Name:
            NameFull: Berger AA
      – PersonEntity:
          Name:
            NameFull: Barrau M
      – PersonEntity:
          Name:
            NameFull: Cheifetz AS
      – PersonEntity:
          Name:
            NameFull: Duru G
      – PersonEntity:
          Name:
            NameFull: Paul S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2050-6414
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: United European gastroenterology journal
              Type: main
ResultId 1